Smartleaf Asset Management
XERS icon

Smartleaf Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

Smartleaf Asset Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.75K Buy
476
+251
+112% +$2.12K ﹤0.01% 2725
2026
Q2 		$1.74K Hold
225
– – ﹤0.01% 2985
2026
Q1 		$1.26K Hold
225
– – ﹤0.01% 3076
2025
Q4 		$1.64K Buy
+225
New +$1.77K ﹤0.01% 3041

Other funds holding XERS

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Smartleaf Asset Management's XERS Position: Q3 2026 in Review

Smartleaf Asset Management increased its Xeris Biopharma Holdings (XERS) stake by 112% in Q3 2026, buying an estimated $2.12K and bringing the position to 476 shares worth $4.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2725.

Smartleaf Asset Management first reported a position in XERS in Q4 2025 and has held it in 4 quarters since. 182 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • Smartleaf Asset Management held 476 shares of Xeris Biopharma Holdings worth $4.75K as of Q3 2026.
  • Smartleaf Asset Management bought 251 Xeris Biopharma Holdings shares in Q3 2026, an estimated $2.12K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #2725 holding.
  • Smartleaf Asset Management first reported a position in Xeris Biopharma Holdings in Q4 2025 and has held it in 4 quarters since.
  • 182 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.